logo
Plus   Neg
Share
Email

Amgen Boosts FY19 Outlook After Otezla Acquisition - Quick Facts

Amgen (AMGN) on Thursday raised its adjusted earnings and revenue guidance for the full-year 2019 following the completion of the Otezla acquisition on Wednesday. Otezla, along with certain related assets and liabilities, was acquired for $13.4 billion in cash, or about $11.2 billion, net of the present value of $2.2 billion in anticipated future cash tax benefits.

For fiscal 2019, the company currently projects earnings adjusted earnings in a range of $14.50 to $14.70 per share on total revenues between $23.1 billion and $23.3 billion.

Previously, the company expected adjusted earnings in the range of $14.20 to $14.45 per share on total revenues between $ $22.8 billion and $23.0 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.79 per share on revenues of $24.85 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>